Medscape5h
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
Hosted on MSN3h
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
ScienceAlert on MSN22h
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.
TheHealthSite.com on MSN6h
US FDA Approves First Of Its Kind Ketamine-Based Nasal Spray To Treat Depression: Know All About This Drug
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
Medical marijuana users can become addicted to pot, study says
People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...
Bird flu isn't an immediate health threat in New York, but preparations have begun
As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...
Daily Journal5h
Doctors testify to mental fitness on final day of Urmeyville murder trial
The trial of a rural Franklin woman who claimed she is God and the man she killed is Satan concluded Thursday.
Johnson & Johnson's SWOT analysis: oncology portfolio drives growth amid challenges
Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...